ADARSH VENNEPUREDDY
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SANDUSKY, OH NPI 1104265156
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OH Acerta Pharma LLC All categories
General Payments — all program years on this page
$7,752.63
- Category: General Payments
- Program years: PY2019–2024
- Record count: 116
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,103.04 across 21 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,725.00 | 3 |
| Food and Beverage | $361.14 | 17 |
| Education | $16.90 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $1,050.00 | 2 |
| BeiGene USA, Inc. | $675.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $71.54 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $56.28 | 2 |
| ABBVIE INC. | $39.57 | 2 |
| ARRAY BIOPHARMA INC | $26.26 | 1 |
| Lilly USA, LLC | $23.57 | 1 |
| Daiichi Sankyo Inc. | $23.13 | 1 |
| Tempus AI, Inc | $20.25 | 1 |
| Gilead Sciences, Inc. | $19.45 | 1 |
| GENZYME CORPORATION | $18.07 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.76 | 1 |
| EISAI INC. | $16.90 | 1 |
| Merck Sharp & Dohme Corporation | $15.68 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.17 | 1 |
| Rigel Pharmaceuticals, Inc. | $14.41 | 1 |
By program year
Records — PY2024 (21)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.